Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Published Data From e-HEALING Registry Demonstrate Good Clinical Outcomes With Low Incidence of Repeat Revascularization and Stent Thrombosis for OrbusNeich’s Genousâ„¢ Stent

February 22, 2011 By Bio-Medicine.Org

HONG KONG, Feb. 22, 2011 /PRNewswire/ — OrbusNeich today
announced that 12-month follow-up data from the e-HEALING
(Healthy Endothelial Accelerated Lining
Inhibits Neointimal Growth) registry published
in the February issue of EuroIntervention
demonstrated good clinical outcomes with low incidence of
repeat revascularization and stent thrombosis (ST) for the
company’s Genous Stent.

Target vessel failure (TVF), defined as target vessel-related
cardiac death or myocardial infarction (MI) and target vessel
revascularization (TVR), was 8.4 percent at 12 months. The
composite of death, MI or target lesion revascularization (TLR)
occurred in 7.9 percent of the patients. TLR and ST were 5.7
percent and 1.1 percent, respectively.

“The good clinical outcomes for the Genous Stent in real-world
use, especially the low incidence of stent thrombosis, demonstrate
that the pro-healing approach of the Genous Stent is effective for
a range of challenging patient groups,” said Professor Sigmund
Silber, M.D., Ph.D., of the Kardiologische Klinik Dr Muller,
Munich, co-principal investigator and one of the lead authors of
the publication. “As shown previously in several subset analyses of
the e-HEALING registry, the Genous Stent produces exceptional
outcomes in diabetic and elderly patients.”

e-HEALING, a multi-center, worldwide prospective clinical
registry conducted in 31 countries outside of the United States at
144 centers, included 4,939 patients with at least one lesion
suitable for non-urgent percutaneous coronary intervention (PCI)
and Genous Stent implantation. The mean age of the study population
was 63 years, and 79 percent of patients were male. In addition, 25
percent of patients in the study cohort had diabetes mellitus, and
37 percent had a prior MI. On average, 1.3 lesions per patient were
treated – 97.7 percent were de

‘/>”/>

SOURCE

Related Articles Read More >

Engineer inspecting artificial hip joint parts in quality control department in orthopaedic factory
Deburring and finishing for beautiful, functional medical devices
A Medtronic HVAD pump opened up to show the inner workings
FDA designates new Medtronic HVAD pump implant recall as Class I
Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age

DeviceTalks Weekly.

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech